SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-035233
Filing Date
2023-03-21
Accepted
2023-03-21 19:36:00
Documents
2
Period of Report
2023-03-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2310127d8_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2310127d8_3seq1.xml 3 4182
2 EXHIBIT 24 tm2310127d8_ex24.htm EX-24 3378
  Complete submission text file 0001104659-23-035233.txt   9084
Mailing Address C/O EPIRUS BIOPHARMACEUTICALS, INC. 699 BOYLSTON STREET, 8TH FLOOR BOSTON MA 02116
Business Address
Munshi Amit (Reporting) CIK: 0001612551 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40598 | Film No.: 23750953

Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Issuer) CIK: 0001855644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)